Literature DB >> 12927915

Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis.

Binay K De1, Debabrata Majumdar, Debasish Das, Pranab K Biswas, Sanjay K Mandal, Sujay Ray, Kausik Bandopadhyay, Tapas K Das, Sanjay Dasgupta, Supriya Guru.   

Abstract

BACKGROUND/AIMS: In cirrhosis, diastolic dysfunction of heart is well documented. Contribution of portal hypertension towards cardiac changes in cirrhosis is difficult to assess. We examined the patients of non-cirrhotic portal fibrosis who have portal hypertension without liver insufficiency to understand the contribution of portal hypertension in causing cardiac changes.
METHODS: Cardiac function was studied in four groups of patients: normal controls, patients with non-cirrhotic portal fibrosis (having portal hypertension without liver dysfunction) and cirrhotics with and without ascites. Cardiac function was evaluated by echocardiography. Additional measurements of plasma renin activity and aldosterone levels were performed.
RESULTS: Diastolic function as assessed by the ratio between E wave and A wave (E/A ratio), was significantly lower in patients with non-cirrhotic portal fibrosis (median 1.3) compared to normal controls (median 1.52). However, even lower values were observed in cirrhotics without ascites (median 1.05) and with ascites (median 0.94). There was a significant correlation (r=-0.75) between plasma aldosterone levels and the E/A ratio in cirrhotics.
CONCLUSIONS: Diastolic dysfunction is not only present in cirrhosis but also in non-cirrhotic portal fibrosis. It indicates that portal hypertension is an important factor in the genesis of cardiac dysfunction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12927915     DOI: 10.1016/s0168-8278(03)00271-x

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

1.  Life-threatening variceal hemorrhage in a woman with severe pulmonary arterial hypertension.

Authors:  Bashar Almadani; Namita Sood; Martha Yearsley; William M Lee
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-06

Review 2.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

3.  Pre- and postoperative systemic hemodynamic evaluation in patients subjected to esophagogastric devascularization plus splenectomy and distal splenorenal shunt: a comparative study in schistomomal portal hypertension.

Authors:  Roberto de Cleva; Paulo Herman; Luis Augusto Carneiro D'albuquerque; Vincenzo Pugliese; Orlando Luis Santarem; William Abrão Saad
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

Review 4.  Diastolic dysfunction in cirrhosis.

Authors:  Søren Møller; Signe Wiese; Hanne Halgreen; Jens D Hove
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

Review 5.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

6.  Cirrhotic cardiomyopathy.

Authors:  M Grancea-Iancu
Journal:  J Med Life       Date:  2014

7.  Effect of gallic acid on electrophysiological properties and ventricular arrhythmia following chemical-induced arrhythmia in rat.

Authors:  Ghaidafeh Akbari; Mahin Dianat; Mohammad Badavi
Journal:  Iran J Basic Med Sci       Date:  2020-02       Impact factor: 2.699

Review 8.  Molecular mechanisms underlying gallic acid effects against cardiovascular diseases: An update review.

Authors:  Ghaidafeh Akbari
Journal:  Avicenna J Phytomed       Date:  2020 Jan-Feb

9.  The Correlation between Echocardiographic Findings and QT Interval in Cirrhotic Patients.

Authors:  Alireza Moaref; Mahmood Zamirian; Maryam Yazdani; Oveis Salehi; Mehrab Sayadi; Kamran Aghasadeghi
Journal:  Int Cardiovasc Res J       Date:  2014-04-01

Review 10.  What's New in Cirrhotic Cardiomyopathy?-Review Article.

Authors:  Aleksandra Bodys-Pełka; Maciej Kusztal; Joanna Raszeja-Wyszomirska; Renata Główczyńska; Marcin Grabowski
Journal:  J Pers Med       Date:  2021-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.